Physician Adherence to Treat-to-Target and Practice Guidelines in Rheumatoid Arthritis
- PMID: 31500394
- PMCID: PMC6780913
- DOI: 10.3390/jcm8091416
Physician Adherence to Treat-to-Target and Practice Guidelines in Rheumatoid Arthritis
Abstract
Principles of treat-to-target (T2T) have been widely adopted in both multinational and regional guidelines for rheumatoid arthritis (RA). Several questionnaire studies among physicians and real-world data have suggested that an evidence-practice gap exists in RA management. Investigating physician adherence to T2T, which requires a process measure, is difficult. Different practice patterns among physicians are observed, while adherence to protocolized treatment declines over time. Rheumatologist awareness, agreement, and claims of adherence to T2T guidelines are not always consistent with medical records. Comorbidities, a difficult disease course, communication barriers, and individual preferences may hinder an intensive, proactive treatment stance. Interpreting deviations from protocolized treatment/T2T guidelines requires sufficient clinical context, though higher adherence seems to improve clinical outcomes. Nonmedical constraints in routine care may consist of barriers in healthcare structure and socioeconomic factors. Therefore, strategies to improve the institution of T2T should be tailored to local healthcare. Educational interventions to improve T2T adherence among physicians may show a moderate, although beneficial effect. Meanwhile, a proportion of patients with inadequately controlled RA exists, while management decisions may not be in accordance with T2T. Physicians tend to be aware of current guidelines, but their institution in routine practice seems challenging, which warrants attention and further study.
Keywords: arthritis; guideline adherence; physicians; physicians’; practice patterns; rheumatoid; rheumatologists; treat-to-target.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Taylor P.C., Balsa Criado A., Mongey A.-B., Avouac J., Marotte H., Mueller R.B., Taylor P.C., Balsa Criado A., Mongey A.-B., Avouac J., et al. How to get the most from methotrexate (MTX) treatment for your rheumatoid arthritis patient?—MTX in the treat-to-target strategy. J. Clin. Med. 2019;8:515. doi: 10.3390/jcm8040515. - DOI - PMC - PubMed
-
- Smolen J.S., Breedveld F.C., Burmester G.R., Bykerk V., Dougados M., Emery P., Kvien T.K., Navarro-Compán M.V., Oliver S., Schoels M., et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann. Rheum. Dis. 2016;75:3–15. doi: 10.1136/annrheumdis-2015-207524. - DOI - PMC - PubMed
-
- Schipper L.G., van Hulst L.T.C., Grol R., van Riel P.L.C.M., Hulscher M.E.J.L., Fransen J. Meta-Analysis of tight control strategies in rheumatoid arthritis: Protocolized treatment has additional value with respect to the clinical outcome. Rheumatology. 2010;49:2154–2164. doi: 10.1093/rheumatology/keq195. - DOI - PubMed
-
- Schoels M., Knevel R., Aletaha D., Bijlsma J.W.J., Breedveld F.C., Boumpas D.T., Burmester G., Combe B., Cutolo M., Dougados M., et al. Evidence for treating rheumatoid arthritis to target: Results of a systematic literature search. Ann. Rheum. Dis. 2010;69:638–643. doi: 10.1136/ard.2009.123976. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
